Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Non-Current Assets (2016 - 2025)

Immucell's Non-Current Assets history spans 16 years, with the latest figure at $25.6 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 14.87% year-over-year to $25.6 million; the TTM value through Dec 2025 reached $113.8 million, down 7.78%, while the annual FY2025 figure was $25.6 million, 14.87% down from the prior year.
  • Non-Current Assets reached $25.6 million in Q4 2025 per ICCC's latest filing, down from $28.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $33.1 million in Q2 2023 to a low of $25.6 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $29.8 million, with a median of $29.8 million recorded in 2022.
  • Peak YoY movement for Non-Current Assets: grew 15.38% in 2023, then fell 14.87% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $28.2 million in 2021, then increased by 9.45% to $30.9 million in 2022, then rose by 4.77% to $32.3 million in 2023, then fell by 7.05% to $30.1 million in 2024, then fell by 14.87% to $25.6 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Non-Current Assets are $25.6 million (Q4 2025), $28.9 million (Q3 2025), and $29.6 million (Q2 2025).